Blog
RSS FeedPosted by Michael Wonder on 03 Jun 2021
Health Canada accepts new drug submission for Reduvo as a treatment for patients with chemotherapy-induced nausea and vomiting
2 June 2021 - Tetra Bio-Pharma announced today that Health Canada has accepted its new drug submission for Reduvo and has ...
Posted by Michael Wonder on 02 Jun 2021
Health Canada approves Opdivo (nivolumab) plus Yervoy (ipilimumab) as the first and only immunotherapy treatment for previously untreated unresectable malignant pleural mesothelioma
2 June 2021 - First new systemic therapy in more than 15 years for cancer related to asbestos exposure. ...
Posted by Michael Wonder on 01 Jun 2021
Health Canada approves Abecma (idecabtagene vicleucel), the first and only anti-BCMA CAR T cell therapy for relapsed and refractory multiple myeloma
31 May 2021 - Abecma is the first personalised cell therapy available to Canadian patients for the treatment of adults ...
Posted by Michael Wonder on 20 May 2021
Canada's change to Pfizer vaccine storage temperature has major implications on rollout
19 May 2021 - Health Canada now recommends storing Pfizer vaccine at fridge temperatures for up to 1 month. ...
Posted by Michael Wonder on 06 May 2021
Health Canada issues Notice of Compliance for Bausch Health's Bryhali
5 May 2021 - Bausch Health Canada today announced that Health Canada has approved the use of Bryhali (halobetasol propionate 0.01% ...
Posted by Michael Wonder on 05 May 2021
Health Canada authorises use of the Pfizer-BioNTech COVID-19 vaccine in children 12 to 15 years of age
5 May 2021 - Today, Health Canada authorised the use of the Pfizer-BioNTech COVID-19 vaccine in children 12 to 15 ...
Posted by Michael Wonder on 03 May 2021
Statement from Health Canada on Janssen COVID-19 vaccines and Emergent BioSolutions
30 April 2021 - Health Canada continues to ensure the quality and safety of vaccines coming into Canada by working ...
Posted by Michael Wonder on 30 Apr 2021
Ilaris receives Health Canada approval as first of its kind treatment for rare, inflammatory disorder, adult-onset Still's disease
29 April 2021 - The approval of Ilaris (canakinumab) in the treatment of adult-onset Still's disease brings hope for Canadians living ...
Posted by Michael Wonder on 28 Apr 2021
Rockwell Medical announces marketing approval of Triferic AVNU in Canada
27 March 2021 - Rockwell Medical today announced that Triferic AVNU (ferric pyrophosphate citrate injection) received a Notice of Compliance (marketing ...
Posted by Michael Wonder on 27 Apr 2021
Health Canada initiates the review of the rolling submission for the first Canadian based COVID-19 vaccine candidate
23 April 2021 - Medicago is pleased to announce that Health Canada received for review the first portion of Medicago’s ...
Posted by Michael Wonder on 23 Apr 2021
AbbVie receives Health Canada approval of Humira (adalimumab) for the treatment of paediatric patients with moderately to severely active ulcerative colitis
22 April 2021 - Approval based on results from the pivotal Phase 3 ENVISION I trial, the largest clinical trial in ...
Posted by Michael Wonder on 19 Apr 2021
Darzalex SC becomes the first and only Health Canada approved treatment for patients with newly diagnosed light chain amyloidosis, a rare disease
19 April 2021 - Darzalex SC combination regimen is supported by the Phase 3 ANDROMEDA study demonstrating a significantly higher haematologic ...
Posted by Michael Wonder on 17 Apr 2021
Health Canada authorises Evrysdi (risdiplam) for the treatment of spinal muscular atrophy in adults and children
15 April 2021 - Evrysdi (risdiplam) is the first at home administered treatment for spinal muscular atrophy. ...
Posted by Michael Wonder on 15 Apr 2021
Health Canada stands by approval of AstraZeneca, Johnson & Johnson COVID-19 vaccines
14 April 2021 - Health Canada is standing by the approval of the Oxford-AstraZeneca and Johnson & Johnson vaccines for ...
Posted by Michael Wonder on 08 Apr 2021
Teva Canada announces new auto-injector for Ajovy for the preventive treatment of migraine in adults
8 April 2021 - Ajovy now offers patients greater flexibility with two dosing options available in both an auto-injector and a ...